Log in or Sign up for Free to view tailored content for your specialty!
Multiple Sclerosis News
New imaging confirms ocrelizumab’s impact on lesion activity in multiple sclerosis
WEST PALM BEACH, Fla. — Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, findings confirmed by data from a series of new imaging techniques and presented at ACTRIMS.
Large language model may improve diagnosis of multiple sclerosis
WEST PALM BEACH, Fla. — Large language model algorithms may be reliable for synthesizing large patient databases to more rapidly and accurately diagnose multiple sclerosis, according to a poster presented at ACTRIMS.
Fampridine may have positive impact for optic neuritis in multiple sclerosis
WEST PALM BEACH, Fla. — Treatment with fampridine may positively impact patients with multiple sclerosis who are recovering from optic neuritis, but more extensive clinical trials are required to fully assess its effectiveness, according to a poster at ACTRIMS.
Log in or Sign up for Free to view tailored content for your specialty!
AI helps identify psychiatric comorbidities in multiple sclerosis
WEST PALM BEACH, Fla. — A machine learning model using existing clinical data may help clinicians screen for comorbid anxiety and depression in patients with multiple sclerosis, according to a poster presented at ACTRIMS.
Tolebrutinib particularly beneficial in patients with MS who have more MRI lesions
WEST PALM BEACH, Fla. — Tolebrutinib had the most protective effect against disability worsening at 6 months in patients with multiple sclerosis who had a greater number of MRI paramagnetic rim lesions at baseline, data show.
Calorie-restricted, keto diets may reduce biological age in multiple sclerosis
WEST PALM BEACH, Fla. — A 6-month ketogenic diet and 2-month calorie-restricted diet were associated with significant reductions in biological age in patients with relapsing-remitting multiple sclerosis, according to a poster at ACTRIMS.
Real-world ublituximab for MS demonstrates similar clinical benefits as in phase 3 studies
WEST PALM BEACH, Fla. — Real-world effects of ublituximab after 1 year of administration were consistent with data from a pair of phase 3 clinical trials investigating the drug, according to a poster presented at ACTRIMS.
ADHD linked to earlier age at MS diagnosis
WEST PALM BEACH, Fla. — Researchers have identified a positive association between multiple sclerosis and ADHD, as well as a trend toward an earlier diagnosis of MS among those with ADHD, according to a poster presented at ACTRIMS.
Risks of ending disease-modifying therapy may be ‘minimal’ in older, stable adults with MS
WEST PALM BEACH, Fla. — It may be sensible for older patients with MS who have prolonged stability to cease disease-modifying therapy, but more data are needed to understand the effects of discontinuation in this group, an expert said.
Physical activity lowers risk for disability worsening in multiple sclerosis
WEST PALM BEACH, Fla. — For patients with MS, the risk for disability worsening was reduced with physical activity, highlighting the importance of recommending it in practice, researchers reported at ACTRIMS.
-
Headline News
Diabetes mortality rates declined in US from 2000 to 2019
March 10, 20253 min read -
Headline News
Of mice and men: Hantavirus infections represent a global problem
March 10, 20258 min read -
Headline News
Q&A: ‘Normal’ blood glucose may still increase risk for heart disease
March 10, 20254 min read
-
Headline News
Diabetes mortality rates declined in US from 2000 to 2019
March 10, 20253 min read -
Headline News
Of mice and men: Hantavirus infections represent a global problem
March 10, 20258 min read -
Headline News
Q&A: ‘Normal’ blood glucose may still increase risk for heart disease
March 10, 20254 min read